scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1014867819 |
P356 | DOI | 10.1186/CC11671 |
P932 | PMC publication ID | 3682289 |
P698 | PubMed publication ID | 23036303 |
P5875 | ResearchGate publication ID | 232085838 |
P2093 | author name string | Petr Ostadal | |
Petr Neuzil | |||
Miroslav Prucha | |||
Marek Janotka | |||
Andreas Kruger | |||
Dagmar Vondrakova | |||
Vladimira Zdrahalova | |||
P2860 | cites work | Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia | Q29615548 |
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest | Q29615549 | ||
Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; th | Q33380595 | ||
Predicting neurological outcome after cardiac arrest. | Q33827879 | ||
Assessment of outcome after severe brain damage | Q34216702 | ||
Hormonal responses upon return of spontaneous circulation after cardiac arrest: a retrospective cohort study | Q35566976 | ||
Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure | Q35748736 | ||
Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscita | Q37307270 | ||
The stress hormone copeptin: a new prognostic biomarker in acute illness | Q37792919 | ||
Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure. | Q39984342 | ||
Copeptin: a novel, independent prognostic marker in patients with ischemic stroke | Q43207505 | ||
Nitrotyrosine and nitrate/nitrite levels in cardiac arrest survivors treated with endovascular hypothermia | Q43420029 | ||
Copeptin and Peroxiredoxin-4 Independently Predict Mortality in Patients With Nonspecific Complaints Presenting to the Emergency Department | Q57759242 | ||
Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD | Q57759362 | ||
C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study | Q83394499 | ||
Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction | Q83455763 | ||
Usefulness of pre-operative copeptin concentrations to predict post-operative outcome after major vascular surgery | Q84613775 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiac arrest | Q202837 |
hypothermia | Q1036696 | ||
P304 | page(s) | R187 | |
P577 | publication date | 2012-10-04 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermia | |
P478 | volume | 16 |
Q36222704 | Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study |
Q38249996 | Copeptin as a biomarker in heart failure |
Q94450964 | Copeptin as a marker of outcome after cardiac arrest: a sub-study of the TTM trial |
Q35555800 | Copeptin levels are associated with organ dysfunction and death in the intensive care unit after out-of-hospital cardiac arrest |
Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
Q26866090 | How to assess prognosis after cardiac arrest and therapeutic hypothermia |
Q33740059 | Risk stratification in emergency patients by copeptin |
Search more.